Shanghai INT Medical Instruments Eyes Majority Stake in Vascular Interventional Medical Device Firm

MT NewswiresDec 18 19:34

INT MEDICAL (01501.HK) plans to acquire at least 51% equity in Hangzhou Weiqiang Medical Technology.

On December 18, Guolonghui reported that INT MEDICAL (01501.HK) announced that on December 18, 2024, the company, the target company Hangzhou Weiqiang Medical Technology Co., Ltd., and other target group companies have signed a Memorandum of Understanding for Acquisition. According to this agreement, the company has conditionally agreed to acquire at least 51% of the controlling equity of the target company through capital increase and by purchasing shares from certain shareholders of the target company. According to the Memorandum of Understanding for Acquisition, the company has conditionally agreed to increase its capital in the target company by no less than 200 million RMB after the acquisition. According to the Memorandum of Understanding for Acquisition, the company or its designated third party must complete the acquisition.

Gelonghui FinanceDec 18 18:11

INT MEDICAL: (1) GRANT OF RESTRICTED SHARES UNDER THE SHARE INCENTIVE SCHEME; AND (2) CLARIFICATION ANNOUNCEMENT

HKEXDec 13 19:21 · Announcements

INT MEDICAL (01501.HK) received an additional Shareholding of 0.04 million shares Listed in Hong Kong from China Orient Asset Management (International) Holding Limited, valued at approximately 1.158 million Hong Kong dollars.

According to a report on December 13, based on documents disclosed by the Hong Kong Stock Exchange on December 13, China Orient Asset Management (International) Holding Limited increased its Shareholding in $INT MEDICAL (01501.HK)$ by 0.04 million shares of Listed in Hong Kong at an average price of 28.95 Hong Kong dollars per share, valued at approximately 1.158 million Hong Kong dollars. After the increase, China Orient Asset Management (International)

Futu NewsDec 13 17:06

INT MEDICAL: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2023 ANNUAL REPORT

HKEXDec 4 22:28 · Announcements

Int Medical (01501.HK) established two joint ventures to expand enterprise management and non-surgical treatment products.

Int Medical (01501.HK) announced a related party transaction, establishing a joint venture, Shanghai Int Medical Asset Management, with Lin Sen, Song Yuan, and Wang Ruiqin, which will primarily engage in asset management. The registered capital of Shanghai Int Medical Asset Management will be 20 million yuan, with the company, Lin Sen, Song Yuan, and Wang Ruiqin contributing 14 million, 2 million, 2 million, and 2 million yuan respectively, representing 70%, 10%, 10%, and 10% of the registered capital. Shanghai Int Medical Asset Management will become a non-wholly-owned subsidiary of the company. The operation scope of Shanghai Int Medical Asset Management includes industrial investment; venture capital; technical services.

AASTOCKSNov 29 09:45